This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »CIN Special Report: Part I, Can a Dangerous Pre-Cancer Threat Be Tamed?
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.
Read more »OneMedRadio Discusses Gene Therapy and Diagnostics with Dr. Andrew Senyei
OneMedRadio interviewed, Andrew Senyei, an MD with an interest in individualized DNA sequencing and gene therapy for heart disease.
Read more »Apricus Bio VP: Drug Delivery Space Is Evolving During Personalized Medicine Surge
Apricus Bio VP Edward Cox discusses the future of drug delivery technology in the rapidly expanding world of personalized medicine.
Read more »New York Biotechnology Association Gears Up for its 21st Annual Meeting
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase at the NYBA 21st Annual Meeting, May 2 in New York City at the Marriott Marquis Hotel.
Read more »Editor’s Note April 24, 2012
This week, OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life […]
Read more »Dr. Shi of EdgeTech Law: Genome Sequencing Could Soon Enter Mainstream
In Part III of our interview with Dr. Qin Shi of Edgetech Law we visit the concept of human genome sequencing as a mainstream commodity.
Read more »NeuroMetrix to Support Study at the Joslin Diabetes Center
NeuroMetrix is investigating the impact of intensive Diabetes management on Diabetic Peripheral Neuropathy
Read more »This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »Dr. Shi of EdgeTech Law: Emerging Opportunities in Life Sciences, Abroad
In Part II of our special interview series, Dr. Qin Shi of Edgetech Law discusses the emerging areas of significant unmet need in life science, and what investment opportunities may arise.
Read more »